Procalcitonin as an early marker in the detection of intestinal anastomotic leakage, in a university hospital from Bogotá

Autor: Benítez Navarrete, Elkin Eduardo, Mosquera González, Maria Fernanda, Martinez Rojas, Valeria, Beltrán García, Tatiana Carolina
Přispěvatelé: Figueroa Avendaño, Carlos Edgar
Jazyk: Spanish; Castilian
Rok vydání: 2020
Předmět:
Zdroj: Giaccaglia V, Salvi PF, Cunsolo GV, Sparagna A, Antonelli MS, Nigri G, et al. Procalcitonin, as an early biomarker of colorectal anastomotic leak, facilitates enhanced recovery after surgery. Journal of Critical Care. 2014 Aug;29(4):528–32.
Lagoutte N, Facy O, Ravoire A, Chalumeau C, Jonval L, Rat P, et al. C-reactive protein and procalcitonin for the early detection of anastomotic leakage after elective colorectal surgery: Pilot study in 100 patients. Journal of Visceral Surgery. 2012 Oct;149(5):e345–9.
Giaccaglia V, Salvi PF, Antonelli MS, Nigri G, Pirozzi F, Casagranda B, et al. Procalcitonin Reveals Early Dehiscence in Colorectal Surgery: The PREDICS Study. Annals of Surgery. 2016 May;263(5):967–72.
Ramos Fernández M, Rivas Ruiz F, Fernández López A, Loinaz Segurola C, Fernández Cebrián JM, de la Portilla de Juan F. Proteína C reactiva como predictor de fuga anastomótica en cirugía colorrectal. Comparación entre cirugía abierta y laparoscópica. Cirugía Española. 2017 Nov;95(9):529–35.
Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased Local Recurrence and Reduced Survival From Colorectal Cancer Following Anastomotic Leak: Systematic Review and Meta-Analysis. Annals of Surgery. 2011 May;253(5):890–9.
Bosmans JWAM, Jongen ACHM, Bouvy ND, Derikx JPM. Colorectal anastomotic healing: why the biological processes that lead to anastomotic leakage should be revealed prior to conducting intervention studies. BMC Gastroenterology [Internet]. 2015 Dec [cited 2019 Nov 20];15(1). Available from: http://www.biomedcentral.com/1471-230X/15/180
Skandalakis JE. Skandalakis’ cirugía: bases de la anatomía quirúrgica. Madrid: Marbán; 2015
Hayati F, Mohd Azman ZA, Nasuruddin DN, Mazlan L, Zakaria AD, Sagap I. Serum Procalcitonin Predicts Anastomotic Leaks in Colorectal Surgery. Asian Pac J Cancer Prev. 2017 27;18(7):1821–5.
Pacheco MA, Aldana GE, Martínez LE, Forero JC, Gómez CA, Coral EM, et al. Incidencia de falla anastomótica en intestino delgado, colon y recto, Bogotá, Colombia. rev colomb cir. 2017 Dec 4;32(4):269–76.
Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 Update. Critical Care Medicine. 2018 Jun;46(6):997–1000.
Hirst NA, Tiernan JP, Millner PA, Jayne DG. Systematic review of methods to predict and detect anastomotic leakage in colorectal surgery. Colorectal Dis. 2014 Feb;16(2):95– 109.
Reith HB, Mittelkötter U, Wagner R, Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Medicine. 2000 Feb;26(2):S165–9.
Di Filippo A, Lombardi A, Ognibene A, Messeri G, Tonelli F. Procalcitonin as an early marker of postoperative infectious complications. Minerva Chir. 2002 Feb;57(1):59– 62.
Reisinger KW, Poeze M, Hulsewé KWE, van Acker BA, van Bijnen AA, Hoofwijk AGM, et al. Accurate Prediction of Anastomotic Leakage after Colorectal Surgery Using Plasma Markers for Intestinal Damage and Inflammation. Journal of the American College of Surgeons. 2014 Oct;219(4):744–51
Su’a BU, Mikaere HL, Rahiri JL, Bissett IB, Hill AG. Systematic review of the role of biomarkers in diagnosing anastomotic leakage following colorectal surgery. British Journal of Surgery. 2017 Apr;104(5):503–12
Karliczek A, Harlaar NJ, Zeebregts CJ, Wiggers T, Baas PC, van Dam GM. Surgeons lack predictive accuracy for anastomotic leakage in gastrointestinal surgery. International Journal of Colorectal Disease. 2009 May;24(5):569–76.
Komen N, Slieker J, Willemsen P, Mannaerts G, Pattyn P, Karsten T, et al. Acute phase proteins in drain fluid: a new screening tool for colorectal anastomotic leakage? The APPEAL study: analysis of parameters predictive for evident anastomotic leakage. The American Journal of Surgery. 2014 Sep;208(3):317–23.
Nargis W, Ahamed B, Ibrahim M. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. International Journal of Critical Illness and Injury Science. 2014;4(3):195.
Maruna P, Nedelníková K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49 Suppl 1:S57-61.
Takakura Y, Hinoi T, Egi H, Shimomura M, Adachi T, Saito Y, et al. Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery. Langenbeck’s Archives of Surgery. 2013 Aug;398(6):833–9.
Oberhofer D, Juras J, Pavicić AM, Rancić Zurić I, Rumenjak V. Comparison of Creactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery. Croat Med J. 2012 Dec;53(6):612–9.
Garcia-Granero A, Frasson M, Flor-Lorente B, Blanco F, Puga R, Carratalá A, et al. Procalcitonin and C-Reactive Protein as Early Predictors of Anastomotic Leak in Colorectal Surgery: A Prospective Observational Study. Diseases of the Colon & Rectum. 2013 Apr;56(4):475–83.
Zawadzki M, Czarnecki R, Rzaca M, Obuszko Z, Velchuru VR, Witkiewicz W. Creactive protein and procalcitonin predict anastomotic leaks following colorectal cancer resections – a prospective study. Videosurgery and Other Miniinvasive Techniques. 2015;4:567–73.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191–4.
Ministerio de Salud C. Resolución número 8430. 1993;11:3-3.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
DOI: 10.48713/10336_20913
Popis: Introducción: La fuga anastomótica, es una complicación de las anastomosis intestinales con una incidencia del 2-7% en los centros de experiencia(1). Para lograr una detección precoz se incluyen los marcadores serológicos como la Procalcitonina(2). Métodos: Cohorte retrospectiva, pacientes llevados a cirugía colorectal con anastomosis intestinal, el objetivo es estimar asociación de procalcitonina (≥2ng/dL) cómo marcador inflamatorio temprano y la fuga anastomótica, en Servicio de Coloproctología de hospital de cuarto nivel, entre Septiembre 2017 y Enero 2019. Resultados: Cohorte de 237 pacientes, 51% mujeres (18-89 años), con comorbilidades en el 81%, incluyendo inmunosupresión, cáncer de colon fue la patología más operada (53,1%). El abordaje laparoscópico el más aplicado 60,34%, anastomosis colorrectal la más realizada (47,26%). Anastomosis ileocolónica presentó mayor frecuencia 43,75% de dehiscencia. La fuga anastomótica esta asociada a procalcitonina sérica positiva al 3 día postoperatorio (X2: 8,68, gl:1, valor p
Databáze: OpenAIRE
Externí odkaz: